Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.

Benefit of Prophylaxis for High-Risk Surgical Patients

Benefit of Prophylaxis for High-Risk Surgical Patients

Pompe

Pompe

About Type 2 Inflammation – Nasal Polyps

About Type 2 Inflammation – Nasal Polyps

Slowing of brain atrophy with Teriflunomide

Slowing of brain atrophy with Teriflunomide

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Risk for Post-operative Venous Thromboembolism in Patients Receiving Enoxaparin Prophylaxis

Risk for Post-operative Venous Thromboembolism in Patients Receiving Enoxaparin Prophylaxis

Low anti-Factor Xa indicative of inadequate enoxaparin dosing is associated with a higher incidence of post-surgical Venous Thromboembolism.

Trends in Pulmonary Embolism-related mortality in Europe

Trends in Pulmonary Embolism-related mortality in Europe

An analysis of vital registration data from the WHO Mortality Database (2000-2015).

2019 ESC Guidelines for Acute Pulmonary Embolism

2019 ESC Guidelines for Acute Pulmonary Embolism

The guidelines provide an update on the 2014 guidelines.

Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.